SC Launch, Inc. Announces Third Investment in Zylö Therapeutics
SCRA’s investment affiliate, SC Launch, Inc. has made its third investment into Zylö Therapeutics, Inc. This $300,000 investment will help the company continue providing therapeutic topical solutions.
Zylö Therapeutics became an SCRA Member Company in 2018 and received a $21,500 Project Development Fund Grant. They also received a $41,000 SBIR/STTR Matching Grant in 2020. Zylö also became an SC Launch, Inc. Portfolio Company in 2019 when they received their first investment of $200,000. They also received a $182,500 investment as part of SC Launch, Inc.’s pandemic funding round to startups providing COVID-19 solutions. Read more.
Public Funds for Tech Development with Matt Bell and Kyle Salazar
Our very own Matt Bell, Director of SC Launch, was recently featured in Scribble SC'sOf Note Podcast. Matt and Kyle Salazar, Program Manager at 3PhaseSC, speak about what it takes to secure grants from their respective programs, and what it means for a new business to pursue public funding. Listen now.
Validide Poised to Disrupt the Personal Identity Market Announces New Name and Website Launch
Validide Corporation, an SCRA Member Company, premiered its first branded product, Thrivacy, and the launch of its new website, thrivacy.io, ahead of the release of all our new full product offerings scheduled for early winter 2022. Read more.